COMMON EQUITY (Tables)

9 Months Ended

Sep. 30, 2022

Equity [Abstract]

Schedule of stock-based compensation awards granted

During the nine months ended September 30, 2022, the Compensation Committee of our Board of Directors awarded the following stock-based compensation to our directors, officers, and certain other key employees:

Award Type	Number of Awards
Stock options (1)	437,269
Restricted shares (2)	72,211
Performance units	171,492

(1)Stock options awarded had a weighted-average exercise price of $96.04 and a weighted-average grant date fair value of $14.71 per option.

(2)Restricted shares awarded had a weighted-average grant date fair value of $96.04 per share.